The Covid-19 crisis has somewhat overshadowed the existence of other threats, such as the alarming emergence of antibiotic-resistant bacteria, which results in a daily death toll of about 20 people in Israel. The research team focuses on the use of bacteriophages – viruses that kill bacteria efficiently and precisely. A significant advantage in using bacteriophages is the researchers’ ability to change and adapt them when a bacterium develops resistance. In addition, because they accurately target bacteria, they do not cause damage to the “beneficial” microbiome bacteria. Furthermore, their accuracy ensures that the treatment is personally tailored to each patient.